Cell cycle
A single human cell spends roughly 91% of its life in a state called interphase, preparing for the brief moment when it splits into two. This long period includes three distinct phases: G1, S, and G2, followed by the M phase where actual division occurs. During G1, the first growth phase, the cell increases its supply of proteins and organelles like mitochondria and ribosomes to prepare for DNA synthesis. The duration of this phase varies wildly even among cells of the same species, sometimes lasting days or weeks depending on external signals. In the subsequent S phase, the cell doubles its entire genetic code so that each new daughter cell receives a complete set of instructions. While RNA transcription slows down during this time, histone production peaks to package the newly copied DNA. The final preparatory stage is G2, where rapid protein synthesis builds the machinery needed for mitosis. Before entering the M phase, the cell must pass through a strict checkpoint ensuring no damage exists within the chromosomes.
Leland Hartwell, Tim Hunt, and Paul Nurse won the 2001 Nobel Prize for discovering the molecular engines that drive these cycles forward. These researchers identified cyclins and cyclin-dependent kinases as the central regulators controlling progression through specific checkpoints. Cyclins act as regulatory subunits while CDKs serve as catalytic subunits, forming active complexes only when bound together. Different combinations of cyclin-CDK determine which downstream proteins get targeted for activation or inactivation. For instance, Cyclin D appears first when cells receive extracellular growth factors, binding to existing CDK4/6 to form an active complex. This complex then phosphorylates the retinoblastoma susceptibility protein, known as Rb, triggering a cascade that commits the cell to division. In resting cells, levels of Cyclin D stay low, keeping CDK4/6 inactive because they are bound by inhibitors from the INK4 family. As Cyclin D levels rise during a mitogenic stimulus, it progressively phosphorylates Rb until it reaches a hyperphosphorylated state. This change triggers the dissociation of pRB-E2F complexes, allowing gene expression to proceed into the S phase.
Approximately one percent of single-strand DNA damages convert into about 50 endogenous double-strand breaks per cell cycle in normal human cells. These errors usually repair with high fidelity, but mistakes contribute significantly to cancer rates. Three main checkpoints exist to ensure damaged DNA is not passed on: the G1/S checkpoint, the G2/M checkpoint, and the metaphase checkpoint. The G1/S transition acts as a rate-limiting step where the cell checks for sufficient raw materials like nucleotide bases before replicating its genome. An unhealthy or malnourished cell gets stuck at this restriction point, preventing entry into the S phase. The G2/M checkpoint ensures the cell has enough cytoplasm and phospholipids for two daughter cells while verifying that replication timing aligns with developmental needs. During the metaphase checkpoint, the cell confirms that the spindle has formed and all chromosomes are aligned at the equator before anaphase begins. The tumor protein p53 plays a critical role here by triggering control mechanisms at both G1/S and G2/M checkpoints. If DNA damage is detected, p53 either repairs the error or triggers apoptosis to destroy the compromised cell.
Many human cancers possess hyper-activated Cdk4/6 activities, making these enzymes prime targets for drug-based interventions. Scientists developed synthetic inhibitors like palbociclib, ribociclib, and abemaciclib to treat advanced-stage breast cancer. These drugs received FDA approval for hormone-receptor-positive, HER2-negative breast cancer cases. Palbociclib is an orally active inhibitor that demonstrated improved outcomes for patients with ER-positive tumors. The main side effect of these treatments is neutropenia, which can be managed through dose reduction. However, Cdk4/6 targeted therapy only works on cancer types where Rb is expressed; cells lacking this protein show primary resistance. Cancerous growth often accompanies deregulation of Cyclin D-Cdk4/6 activity, leading to uncontrolled multiplication. In tumor formation, the proportion of actively dividing cells is much higher than in normal tissue because fewer cells die via apoptosis. Debunking procedures remove significant tumor mass, pushing remaining cells from a resting state into the cycle. Radiation or chemotherapy then kills these newly activated cells while they are most vulnerable during division.
The pre-cellular environment contained functional self-replicating RNAs that depended entirely on concentrations of other RNAs for survival. Growth in these early structures was simply continuous production without strict regulation until genomic RNA partitioned from functional RNA. This separation allowed parasitic RNAs to face a greater barrier when attempting to incorporate themselves into the genome. Replacing genomic RNA with DNA provided a more stable molecule capable of supporting larger genomes and complex life forms. Modern yeast rely on just one CDK, such as Cdc28 in Saccharomyces cerevisiae, to control their entire cell cycle. Animals evolved whole families of CDKs including Cdk1, Cdk2, Cdk4, and Cdk6 to regulate different phases like mitosis and S phase entry. Despite this complexity, cdk1 knockouts remain lethal in mice, suggesting an ancestral kinase ultimately controls the cycle. Plants like Arabidopsis thaliana possess unique B-type CDKs that may range from development-specific functions to major players in mitotic regulation. The G1/S checkpoint networks across opisthokonts show striking topology similarities despite highly diverged protein sequences.
Up Next
Common questions
What percentage of a human cell's life is spent in interphase?
A single human cell spends roughly 91% of its life in a state called interphase. This long period includes three distinct phases: G1, S, and G2, followed by the M phase where actual division occurs.
Who won the 2001 Nobel Prize for discovering molecular engines that drive the cell cycle forward?
Leland Hartwell, Tim Hunt, and Paul Nurse won the 2001 Nobel Prize for discovering the molecular engines that drive these cycles forward. These researchers identified cyclins and cyclin-dependent kinases as the central regulators controlling progression through specific checkpoints.
How many endogenous double-strand breaks occur per cell cycle in normal human cells?
Approximately one percent of single-strand DNA damages convert into about 50 endogenous double-strand breaks per cell cycle in normal human cells. These errors usually repair with high fidelity, but mistakes contribute significantly to cancer rates.
Which drugs received FDA approval for hormone-receptor-positive HER2-negative breast cancer cases?
Scientists developed synthetic inhibitors like palbociclib, ribociclib, and abemaciclib to treat advanced-stage breast cancer. These drugs received FDA approval for hormone-receptor-positive, HER2-negative breast cancer cases.
Why do modern animals have whole families of CDKs while yeast rely on just one CDK?
Modern yeast rely on just one CDK such as Cdc28 in Saccharomyces cerevisiae to control their entire cell cycle. Animals evolved whole families of CDKs including Cdk1, Cdk2, Cdk4, and Cdk6 to regulate different phases like mitosis and S phase entry.